Nicotinamide downregulates gene expression of interleukin-6, interleukin-10, monocyte chemoattractant protein-1, and tumour necrosis factor-α gene expression in HaCaT keratinocytes after ultraviolet B irradiation by Monfrecola G. et al.
Experimental dermatology • Concise report CED
Clinical and Experimental Dermatology
Nicotinamide downregulates gene expression of interleukin-6,
interleukin-10, monocyte chemoattractant protein-1, and tumour
necrosis factor-a gene expression in HaCaT keratinocytes after
ultraviolet B irradiation
G. Monfrecola, F. Gaudiello, T. Cirillo, G. Fabbrocini, A. Balato and S. Lembo
Department of Dermatology,University of Naples Federico II, Naples, Italy
doi:10.1111/ced.12018
Summary Ultraviolet (UV) radiation has profound effects on human skin, causing sunburn,
inflammation, cellular-tissue injury, cell death, and skin cancer. Most of these effects
are mediated by a number of cytokines produced by keratinocytes. In this study we
investigated whether nicotinamide (NCT), the amide form of vitamin B3, might have
a protective function in reducing the expression of interleukin (IL)-1b, IL-6, IL-8,
IL-10, monocyte chemoattractant protein (MCP)-1 and tumour necrosis factor
(TNF)-a in UV-irradiated keratinocytes. HaCaT cells were treated with UVB in the
presence or absence of NCT, and cytokine mRNA levels were examined by quantita-
tive real-time PCR. NCT significantly downregulated IL-6, IL-10, MCP-1 and TNF-a
mRNA expression, whereas it did not exert any significant effect on IL-1b or IL-8
expression. Because of its ability to decrease these cytokine mediators after UV expo-
sure, NCT is a possible therapy to improve or prevent conditions induced or aggra-
vated by UV light.
Short ultraviolet (UV)B (290–320 nm) is able to
increase levels of interleukin (IL)-1b, IL-6, IL-8, IL-10,
monocyte chemoattractant protein (MCP)-1 and
tumour necrosis factor (TNF)-a gene expression in
keratinocytes. Nicotinamide (NCT), also known as nia-
cinamide, is the pyridine-3-carboxylic acid amine form
of niacin, a component of the vitamin B complex. NCT
is the precursor for nicotinamide adenine dinucleotide
(NAD+), and acts as an inhibitor of poly(ADP-ribose)
polymerase (PARP)-1.1 This enzyme, potentially acti-
vated by UV radiation, decreases cellular energy pro-
duction through glycolytic blockade, resulting in ATP
depletion. Moreover, by enhancing transcription of
nuclear factor jB-mediated transcription, PARP-1
plays a pivotal role in the expression of inflammatory
mediators such as cytokines, chemokines and adhesion
molecules.1,2 As well as its antioxidant and immuno-
modulating effects, NCT has also been shown to have
anti-inflammatory properties after stimulation with
bacterial lipopolysaccharide3 or with Propionibacterium
acnes.4 In addition, in vivo studies have shown that
NCT is able to provide protection against UV-induced
immunosuppression in humans.5,6
The aim of this study was to investigate whether
NCT could modulate UVB-induced expression of IL-1b,
IL-6, IL-8, IL-10, MCP-1 and TNF-a in spontaneously
immortalized HaCaT keratinocytes.
Report
HaCaT cells were treated with UVB in the presence or
absence of NCT, and mRNA levels of IL-1b, IL-6, IL-8,
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IL-10, MCP-1 and TNF-a were measured by quantita-
tive real-time (qRT) PCR.
To calculate the optimal UVB irradiation dose, Ha-
CaT cell viability was determined at 6 and 24 h after
treatment with 5, 25, 50, 100 and 150 mJ/cm2 UVB
(TL12 lamp; Philips, Eindhoven, the Netherlands),
using Trypan blue. UVB irradiation at 5 and 25 mJ/
cm2 did not significantly affect cell viability, whereas
50, 100 and 150 mJ/cm2 induced viability loss of
70%, 40% and 28%, respectively (Fig. 1a). Hence,
UVB 100 mJ/cm2 was chosen as the stimulation dose
for further experiments because it corresponds to the
mean UVB minimal erythema dose for the Italian pop-
ulation, and should therefore reproduce a reliable
in vivo condition.
To identify the optimal dose of NCT, cell viability
was assessed 24 h after treatment with different
doses (50 and 100 lM, and 1, 5 and 10 mM) of
NCT (Sigma-Aldrich St. Louis, MO, USA). We found
that none of the tested concentrations of NCT
affected cell viability (Fig. 1b), therefore two interme-
diate concentrations were chosen: 100 lM and
5 mM.
All statistical analyses were performed using Graph-
Pad Prism (version 4.0; GraphPad Software Inc, La
Jolla, CA, USA). Student t-test was used to calculate
differences between groups, and P < 0.05 was consid-
ered significant.
We assessed the viability of cells pretreated for
30 min with NCT and subsequently irradiated with
UVB. NCT 5 mM resulted in a decrease in the cellular
mortality induced by UVB irradiation, increasing the
cell viability from 40% to 56%, whereas NCT
100 lM did not significantly improve cell viability
(40% vs. 44%) (Fig. 1c). Previous studies performed
on similar cell viability (~40%), and our finding that
NCT (5 mM) was even able to increase it (~60%),
enabled us to rely on such viability values for cyto-
kine gene expression evaluation.7 Thereafter, peaks of
cytokine expression were detected in UVB-treated cells
by monitoring production of specific mRNAs at 6, 12
and 24 h post irradiation.
Similarly, cytokine gene expression was assessed in
cells treated with NCT 100 lM and 5 mM for 6 and
24 h. HaCaT cells were then pretreated with NCT
100 lM and 5 mM for 30 min, irradiated with UVB
at 100 mJ/cm2, and cultured for 6 or 24 h to evalu-
ate the effect of NCT on UVB-induced cytokine gene
expression. Total mRNA was isolated (RNeasy Mini
Kit; Qiagen, Doncaster, Australia), cDNA was pre-
pared (Transcriptor High Fidelity cDNA Synthesis Kit;
Roche, Indianapolis, IN, USA) and gene expression
was analysed using qRT-PCR in a thermal cycler
(LightCycler; Roche) according to the manufacturer’s
instructions.
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Figure 1 The viability of HaCaT cells after ultraviolet (UV)B
exposure and nicotinamide (NCT) treatment. Cell viability was
investigated after (a) exposure to different UVB doses (5, 25, 50,
100 and 150 mJ/cm2) at 6 and 24 h; (b) after incubation with
NCT (50 lM, 100 lM, 1 mM, 5 mM and 10 mM) for 24 h (not
statistically significant); (c) after 30 min pretreatment with NCT
(100 lM or 5 mM) and subsequent irradiation (UVB 100 mJ/
cm2) at 6 and 24 h. Cellular viability rate and statistical signifi-
cance were determined with respect to the 100% viability of
untreated control cells. Data are expressed as means ± SD of
three independent experiments, each performed in duplicate.
Student t-test:.*P < 0.05; **P < 0.01; ***P < 0.001.
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The time-course analysis of the investigated cyto-
kines showed the highest mRNA expression occurred
at 6 h after UVB irradiation for IL-1b, IL-6 and IL-8,
whereas IL-10, MCP-1 and TNF-a mRNA peaks were
recorded at 24 h after UVB exposure (Fig. 2a). No
significant alteration was found after treatment of
nonirradiated cells with NCT for 6 and 24 (data not
shown). Conversely, NCT pretreatment of UVB-irradi-
ated HaCaT cells was able to modulate cytokine gene
expression. This was more effective with the higher
tested concentration of 5 mM, which significantly
reduced IL-6, IL-10, MCP-1 and TNF-a gene expres-
sion but was ineffective for IL-1b and IL-8. NCT
100 lM produced a significant decrease in IL-6, IL-10
and TNF-a, but was ineffective for IL-1b, IL-8 and
MCP-1 (Fig. 2b).
In this study, NCT pretreatment of HaCaT cells
downregulated gene expression of the UVB-induced
cytokines IL-6, IL-10, MCP-1 and TNF-a. NCT was
more effective at the higher tested concentration,
showing a dose-related trend. Moreover, NCT, at both
tested concentrations was safe, with no decrease in
cell viability observed.
Our results for IL-6 are in line with those of Un-
gerstedt3 et al. and Ahn8 et al., who reported a
decrease in IL-6 induced by NCT after exposure to
UV and bacterial endotoxin, respectively. Our find-
ings about the effect of NCT on TNF-a also agree
with those of Ungerstedt et al.3 who found that
endotoxin-induced TNF-a increments were reduced
by NCT. Our results for MCP-1 gene expression are
in accordance with previous studies showing the
ability of NCT to reduce MCP-1 secretion from mul-
tiple cell types exposed to oxidative stress or viral
infection.9 However, our data for IL-1b and IL-8
contrast with those of Grange et al., who found that
a high level of efficacy for NCT in reducing these
cytokines after P. acnes stimulation.4 This might be
due to the fact that in our study IL-1b and IL-8
were only slightly enhanced by UVB, whereas there
was a much more robust increase after the bacterial
stimulation.4
NCT downregulated the UVB-induced overexpression
of IL-10. This effect could modulate the UV-induced
immunosuppression attributed to IL-10 that is thought
to be able to shift the immune response towards a T-
helper 2 pathway and to inhibit Langerhans cell func-
tion. Prevention of UV-induced immunosuppression
has been shown after NCT topical application in men
before or after UV exposure.5,6 This study extends
these findings, as the effect of NCT on IL-10 supports
its anti-immunosuppressive potential and confirms the
the recently proposed NCT preventive treatment for
skin cancer.10
In conclusion, given that regulation of immunomod-
ulatory cytokines is considered an essential part of
treatment in multiple inflammatory diseases and that
we have shown the ability of NCT to decrease these
mediators after UV exposure, NCT may be an interest-
ing option to improve or prevent UV-induced/aggra-
vated clinical conditions.
(a)
(b)
Figure 2 (a) Assessment of cytokine gene expression in HaCaT
cells after ultraviolet (UV)B irradiation (100 mJ/cm2). Dotted line
indicates the reference value, represented by unirradiated HaCaT
cells. mRNA expression of interleukin (IL)-1b, IL-6 and IL-8
reached its maximum at 6 h after UVB irradiation, whereas that
of IL-10, monocyte chemoattractant protein (MCP)-1 and
tumour necrosis factor (TNF)-a peaked at 24 h after UVB expo-
sure. (b) Cytokine gene expression was measured in HaCaT cells
after nicotinamide (NCT) pretreatment and subsequent UVB irra-
diation (100mJ/cm2) vs. unirradiated HaCaT cells (no UVB).
mRNA extraction was performed at 6 h post irradiation to evalu-
ate IL-1b, IL-6 and IL-8, and 24 h post irradiation to assess
IL-10, MCP-1 and TNF-a gene expression. NCT 5 mM signifi-
cantly downregulated IL-6, IL-10, MCP-1 and TNF-a mRNA
expression, but it did not exert any significant effect on IL-1b
and IL-8 expression (b). Relative mRNA levels were determined
by the comparative threshold cycle method and their expression
was normalized to 18S mRNA expression. Student’s t-test was
used to calculate significant differences. Data are expressed as
means ± SD of three independent experiments, each performed in
duplicate. Student t-test:.*P < 0.05; **P < 0.01; ***P < 0.001.
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Learning points
• NCT has antioxidant, immunomodulating and
anti-inflammatory properties.
• NCT is able to modulate UVB-induced expres-
sion of IL-1b, IL-6, IL-8, IL-10, MCP-1 and TNF-
a in HaCaT keratinocytes.
• NCT downregulation of UVB-induced IL-10
overexpression may represent an additional
explanation of its anti-immunosuppressive mech-
anism, supporting the recently proposed use of
NCT as a preventive treatment for skin cancer.
• Because regulation of immunomodulatory cyto-
kines is considered an essential part of treatment
in many inflammatory diseases, NCT may be an
interesting option to improve or prevent clinical
conditions induced or aggravated by UV irradia-
tion.
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